Streaming now on: Amazon Music | Apple Podcasts | Spotify | Soundcloud | YouTube
Learn More About Beyond the Endpoint | View All Episodes
Beyond the Endpoint hosts Emily O'Brien and Manesh Patel delve into the science behind recent medical headlines, providing context and expert analysis. The hosts examine three trending health topics making headlines: the potential of diabetes drug Ozempic (semaglutide) to reduce alcohol consumption, NBA star Victor Wembenyama's diagnosis with deep venous thrombosis (DVT), and a study linking ADHD to reduced life expectancy. For each story, they explore the underlying research, discuss the strengths and limitations of the methodology, and offer practical insights that extend beyond what is reported in the news.
Articles Referenced in this Episode
- Ozempic Can Curb Drinking, New Research Shows (New York Times)
- The Rare Medical Condition That Sidelined the NBA’s Next Superstar (Wall Street Journal)
- Could ADHD Shorten the Lifespan? (Medical News Today)